UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Postgraduate medical journal, ISSN 0032-5473, 12/2016, Volume 92, Issue 1094, pp. 726 - 734
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Vasodilator Agents - therapeutic use | Erythropoietin - therapeutic use | United States | Humans | Calcium Channel Blockers - therapeutic use | Heart Failure - physiopathology | Aminobutyrates - therapeutic use | Cardiotonic Agents - therapeutic use | Societies, Medical | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Isosorbide Dinitrate - therapeutic use | Cardiology | Platelet Aggregation Inhibitors - therapeutic use | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Hematinics - therapeutic use | Fumarates - therapeutic use | Anticoagulants - therapeutic use | Amides - therapeutic use | Antihypertensive Agents - therapeutic use | Evidence-Based Medicine | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | American Heart Association | Stroke Volume | Cardiovascular Agents - therapeutic use | Hydralazine - therapeutic use | Atrial Natriuretic Factor - therapeutic use | Iron - therapeutic use | Benzazepines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Diuretics - therapeutic use | Tetrazoles - therapeutic use | Peptide Fragments - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Practice Guidelines as Topic | Heart failure | Care and treatment | Usage | Analysis | Americans | Diagnosis | Cardiac output | Health aspects | Evidence-based medicine | Index Medicus
Journal Article
European heart journal, ISSN 0195-668X, 2014, Volume 35, Issue 40, pp. 2797 - 2811
Heart failure, Diastolic | Clinical trial | Phenotype | Preserved ejection fraction | Exercise tolerance | Diabetes mellitus | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Humans | Heart Failure - physiopathology | Homeostasis | Anemia - prevention & control | Aminobutyrates - therapeutic use | Hypertension, Pulmonary - prevention & control | Patient Selection | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Iron - deficiency | Observational Studies as Topic | Sodium Channel Blockers - therapeutic use | Phosphodiesterase 5 Inhibitors - therapeutic use | Diabetic Angiopathies - prevention & control | Molecular Targeted Therapy - methods | Exercise Therapy - methods | Arrhythmias, Cardiac - prevention & control | Stroke Volume - physiology | Clinical Trials as Topic | Mineralocorticoid Receptor Antagonists - therapeutic use | Obesity - prevention & control | Vascular Stiffness - physiology | Diuretics - therapeutic use | Tetrazoles - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Index Medicus | Review
Journal Article
European journal of heart failure, ISSN 1388-9842, 07/2014, Volume 16, Issue 7, pp. 817 - 825
Heart failure | Renin–angiotensin system | Neutral endopeptidase | Natriuretic peptides | Renin-angiotensin system | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Humans | Middle Aged | Heart Failure - physiopathology | Male | Treatment Outcome | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Heart Failure - drug therapy | Mineralocorticoid Receptor Antagonists - therapeutic use | Patient Selection | Randomized Controlled Trials as Topic | Stroke Volume | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Quality of Life | Diuretics - therapeutic use | Female | Tetrazoles - therapeutic use | Aged | Platelet Aggregation Inhibitors - therapeutic use | Angiotensin Receptor Antagonists - therapeutic use | Natriuretic Peptide, Brain - blood | Adrenergic beta-Antagonists - therapeutic use | Heart Failure - mortality | Index Medicus | Treatments | Clinical Medicine | heart failure | treatment | Klinisk medicin | prognosis
Journal Article
Canadian Medical Association journal (CMAJ), ISSN 0820-3946, 11/2016, Volume 188, Issue 16, pp. 1137 - 1138
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Canada | Valsartan - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Valsartan - therapeutic use | Tetrazoles - administration & dosage | Humans | Tetrazoles - therapeutic use | Aminobutyrates - administration & dosage | Aminobutyrates - therapeutic use | Chronic Disease | Heart Failure - drug therapy | Randomized Controlled Trials as Topic | Congestive heart failure | Health aspects | Analysis | Cardiac patients | Angiotensin | Heart failure | Hospitals | Mortality | Drug therapy | Acute coronary syndromes | Beta blockers | Drug dosages | Patients | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2014, Volume 371, Issue 11, pp. 993 - 1004
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Biological and medical sciences | General aspects | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Double-Blind Method | Humans | Middle Aged | Kaplan-Meier Estimate | Aminobutyrates - adverse effects | Hospitalization - statistics & numerical data | Male | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Enalapril - adverse effects | Heart Failure - drug therapy | Stroke Volume | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Neprilysin - antagonists & inhibitors | Female | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Angiotensin Receptor Antagonists - adverse effects | Heart Failure - mortality | Heart failure | Enalapril | Patient outcomes | Angiotensin | Enalaprilat | Dosage and administration | Research | Drug therapy | Enzymes | Statistical analysis | Mortality | Angioedema | Hypotension | Cough | Studies | Hyperkalemia | Death | Neprilysin | Heart diseases | Index Medicus | Abridged Index Medicus | MORTALITY | SURVIVAL | RANDOMIZED-TRIAL | RECEPTOR | Klinisk medicin | NEUTRAL ENDOPEPTIDASE INHIBITION | NATRIURETIC-PEPTIDE | Medicine | Clinical Medicine | CONVERTING ENZYME-INHIBITION | MORBIDITY | EJECTION FRACTION | General & Internal | DOUBLE-BLIND
Journal Article
The lancet. Diabetes & endocrinology, ISSN 2213-8587, 2017, Volume 5, Issue 5, pp. 333 - 340
Endocrinology & Metabolism | Other | Life Sciences & Biomedicine | Science & Technology | Heart Failure - complications | Tetrazoles - pharmacology | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Male | Aminobutyrates - pharmacology | Aminobutyrates - therapeutic use | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Heart Failure - drug therapy | Valsartan - pharmacology | Blood Glucose - drug effects | Enalapril - pharmacology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Valsartan - therapeutic use | Female | Tetrazoles - therapeutic use | Aged | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetes Mellitus, Type 2 - complications | Heart failure | Treatment outcome | Care and treatment | Diabetes | Analysis | Index Medicus | Kardiologi | Cardiac and Cardiovascular Systems
Journal Article
7.
Full Text
A putative placebo analysis of the effects of LCZ696 on clinical outcomes in heart failure
European heart journal, ISSN 0195-668X, 2015, Volume 36, Issue 7, pp. 434 - 439
Heart failure | Angiotensin II | Natriuretic peptides | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Placebo Effect | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Treatment Outcome | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Heart Failure - drug therapy | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Female | Tetrazoles - therapeutic use | Aged | Angiotensin Receptor Antagonists - therapeutic use | Benzimidazoles - therapeutic use | Heart Failure - mortality | Index Medicus | Track Clinical Research | Angiotensin II; Heart failure; Natriuretic peptides | Klinisk medicin | Clinical Medicine
Journal Article